06/27/2025
3:45 PM | Harvard Bioscience (Filer)
| Form 8-K/A | |
06/23/2025
3:46 PM | Harvard Bioscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/13/2025
3:45 PM | Harvard Bioscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/09/2025
8:08 PM | Duke John D (Reporting)
Harvard Bioscience (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/02/2025
4:00 PM | Harvard Bioscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/30/2025
10:50 AM | Harvard Bioscience (Subject)
Leviticus Partners LP (Filed by)
| Form SCHEDULE 13G/A | |
05/27/2025
3:36 PM | Harvard Bioscience (Filer)
| Form SD
Specialized Disclosure Report | |
05/14/2025
11:28 AM | Harvard Bioscience (Subject)
Leviticus Partners LP (Filed by)
| Form SCHEDULE 13G/A | |
05/12/2025
3:46 PM | Harvard Bioscience (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/12/2025
6:00 AM | Harvard Bioscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2025
11:45 AM | Harvard Bioscience (Subject)
WEBER CAPITAL MANAGEMENT LLC /ADV (Filed by)
| Form SCHEDULE 13G/A | |
Get the Latest News and Ratings for HBIO and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Harvard Bioscience and its competitors with MarketBeat's FREE daily newsletter. |
04/21/2025
3:45 PM | Harvard Bioscience (Filer)
| Form DEF 14A | |
04/21/2025
3:45 PM | Harvard Bioscience (Filer)
| Form DEFA14A | |
04/10/2025
3:46 PM | Harvard Bioscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/08/2025
8:49 AM | Harvard Bioscience (Subject)
Leviticus Partners LP (Filed by)
| Form SCHEDULE 13G/A | |
03/21/2025
3:49 PM | Green James W (Reporting)
Harvard Bioscience (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2025
3:50 PM | Cote Jennifer (Reporting)
Harvard Bioscience (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/17/2025
9:33 AM | Harvard Bioscience (Subject)
Leviticus Partners LP (Filed by)
| Form SCHEDULE 13G | |
03/12/2025
6:00 AM | Harvard Bioscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/10/2025
3:56 PM | Harvard Bioscience (Subject)
WEBER CAPITAL MANAGEMENT LLC /ADV (Filed by)
| Form SCHEDULE 13G | |
02/04/2025
9:37 AM | Harvard Bioscience (Subject)
Leviticus Partners LP (Filed by)
| Form SCHEDULE 13G/A | |
12/31/2024
3:01 PM | Cote Jennifer (Reporting)
Harvard Bioscience (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/31/2024
3:02 PM | Green James W (Reporting)
Harvard Bioscience (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/29/2024
11:15 PM | Harvard Bioscience (Filer)
| Form EFFECT | |
12/06/2024
6:45 AM | Harvard Bioscience (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
11/14/2024
11:31 AM | 272 Capital LP (Filed by)
Harvard Bioscience (Subject)
| Form SC 13G/A | |
11/08/2024
3:45 PM | Harvard Bioscience (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2024
6:02 AM | Harvard Bioscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
8:00 AM | Harvard Bioscience (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/08/2024
7:29 AM | Harvard Bioscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
